Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041
Business Wire•30/07/2026•08:05 ET
0
Whiz Insights
Get started
Create a free account to read the full story.